Achilles Therapeutics plc (ACHL) NASDAQ
1.48
+0.01(+0.68%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 35.54M |
| Enterprise Value | -91.39M |
| P/E Ratio | -0.85 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.42 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.94 |
Fiscal Year
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | September 30, 2024 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.43 |
| Return On Equity | -0.41 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -4.73M |
| EBITDA | -70.44M |
| Net Income | -69.67M |
| Diluted EPS | -1.74 |
Balance Sheet
| Total Cash | 86.05M |
| Total Cash/Share | 3.29 |
| Total Debt | 3.62M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 8.57 |
| Book Value Per Share | 3.56 |
Price History
| 52-Week Change | 89.04 |
| 52-Week High | 1.51 |
| 52-Week Low | 0.63 |
| Moving Average 50 Days | 1.33 |
| Moving Average 200 Days | 1.03 |
Statistics
| Average Volume | 1.28M |
| Shares Outstanding | 41.1M |
| % Held by Institutions | 0.09 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
